Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (621-630 of 666) with videos related to

Pageof 67
Sort By:
The New England Journal of Medicine|May 3, 1990
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
The New England Journal of Medicine|October 9, 1986
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgeryA G Turpie, M N Levine, J Hirsh, et al.
Thrombosis and Haemostasis|March 1, 1993
An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibitionC Demers, P Henderson, M A Blajchman, et al.
Circulation|October 1, 1996
Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR StudyJ A Cairns, J Gill, B Morton, et al.
Archives of Internal Medicine|September 12, 1994
Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosisJ S Ginsberg, P S Wells, J Hirsh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 14, 2023
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart AssociationLarry B Goldstein, Peter P Toth, Jennifer L Dearborn-Tomazos, et al.
Blood|February 1, 1982
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosisA Zielinsky, J Hirsh, G Straumanis, et al.
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
Pulmonary Pharmacology & Therapeutics|August 13, 2013
Airway drug pharmacokinetics via analysis of exhaled breath condensateCharles R Esther, Richard C Boucher, M Ross Johnson, et al.
Chest|December 1, 1985
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolismR D Hull, J Hirsh, C J Carter, et al.
Pageof 67

Showing results (621-630 of 666) with videos related to

Sort By:
Pageof 67
The New England Journal of Medicine|May 3, 1990
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
The New England Journal of Medicine|October 9, 1986
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgeryA G Turpie, M N Levine, J Hirsh, et al.
Thrombosis and Haemostasis|March 1, 1993
An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibitionC Demers, P Henderson, M A Blajchman, et al.
Circulation|October 1, 1996
Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR StudyJ A Cairns, J Gill, B Morton, et al.
Archives of Internal Medicine|September 12, 1994
Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosisJ S Ginsberg, P S Wells, J Hirsh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 14, 2023
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart AssociationLarry B Goldstein, Peter P Toth, Jennifer L Dearborn-Tomazos, et al.
Blood|February 1, 1982
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosisA Zielinsky, J Hirsh, G Straumanis, et al.
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
Pulmonary Pharmacology & Therapeutics|August 13, 2013
Airway drug pharmacokinetics via analysis of exhaled breath condensateCharles R Esther, Richard C Boucher, M Ross Johnson, et al.
Chest|December 1, 1985
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolismR D Hull, J Hirsh, C J Carter, et al.
Pageof 67